Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil

Molecular and Cellular Biochemistry

Volumn 213, Issue 1-2, 2000, Pages 111-118

  Takeo, S ^a   Elmoselhi, A B ^b   Goel, R ^b   Sentex, E ^b   Wang, J ^b   Dhalla, N S ^b  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Anti hypertensive therapy; Gene expression; Pressure overload; Sarcoplasmic reticulum Ca2+ handling; Subcellular remodeling

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL; CALCIUM ION; MESSENGER RNA; MYOSIN HEAVY CHAIN; PROPRANOLOL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; GENE EXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; MALE; MUSCLE FIBRIL; NONHUMAN; PROTEIN CONTENT; RAT; SARCOPLASMIC RETICULUM;

ANIMALIA;

EID: 0033645997     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007120332587     Document Type: Article

References (58)

1. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats
2. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats
3. Postinfarction survival and inducibility of ventricular arrhythmias in the spontaneously hypertensive rat: Effects of ramipril and hydralazine
4. Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat
5. Therapeutic advances in the treatment of left ventricular hypertrophy
6. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery
7. Effect of antihypertensive therapy upon myosin isozyme distribution in spontaneously hypertensive rats
8. Regression of left ventricular hypertrophy - A meta-analysis
9. Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats
10. Reversal of cardiac and vascular hypertrophy by antihypertensive therapy
11. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis
12. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure
13. The multifactorial role of catecholamines in hypertensive cardiac hypertrophy
14. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence
15. 2+-ATPase in cardiac hypertrophy by angiotensin converting enzyme?
16. 2+ pumps in heart and diaphragm of cardiomyopathic hamster: Effects of perindopril
17. 2+-ATPase gene expression in renal hypertensive rats: Dose-dependent effects of ACE inhibition and AT1-receptor blockade
18. 2+-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy
19. Effect of cilazapril on ventricular remodeling assessed by Doppler-echocardiographic assessment and cardiac gene expression
20. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I
21. Cell death in the failing heart: Role of an unnatural growth response to overload
22. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction
23. Subcellular remodeling and heart dysfunction in cardiac hypertrophy due to pressure overload
24. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan
25. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir
26. Nitrendipine binding in congestive heart failure due to myocardial infarction
27. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy
28. Mechanisms of the defect in cardiac myofibrillar function during diabetes
29. Differential changes in left and right ventricular SR calcium transport in congestive heart failure
30. Modification of ischemia-reperfusion-induced changes in cardiac sarcoplasmic reticulum by preconditioning
31. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
32. Altered mRNA abundance of calcium transport genes in cardiac myocytes induced by angiotensin II
33. Comparisons of rat cardiac myosins at fetal stages in young animals and in hypothyroid adults
34. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure
35. Function of the sarcoplasmic reticulum and expression of its Ca(2(+))-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat
36. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding
37. Role of angiotensin-converting enzyme, adrenergic receptors, and blood pressure in cardiac gene expression of spontaneously hypertensive rats during development
38. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study
39. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medical thickening of intramyocardial coronary arteries
40. Myosin isoenzyme changes in several models of rat cardiac hypertrophy
41. Isomyosin distribution in normal and pressure-overloaded rat ventricular myocardium. An immunohistochemical study
42. Myosin isoenzyme redistribution in chronic heart overload
43. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals
44. The ATPase activities of rat cardiac myosin isoenzymes
45. Left ventricular hypertrophy and antihypertensive therapy
46. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies
47. The arterial baroreceptor reflex of the rat exhibits positive feedback properties at the frequency of mayer waves
48. Therapeutic options in minimizing left ventricular hypertrophy
49. Regulation of cardiac gene expression during myocardial growth and hypertrophy: Molecular studies of an adaptive physiologic response
50. Response of blood pressure and cardiac myosin polymorphism to swimming training in the spontaneously hypertensive rat
51. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure
52. Hormone response domains in gene transcription
53. Molecular medicine. Transcription factors
54. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy
55. Cardiac dimensions in spontaneously hypertensive rats following different modes of blood pressure reduction by antihypertensive treatment
56. Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats
57. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components
58. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart